LRMR Earnings

Quarterly EPS
$-0.24
Q3 2024
$-0.45
Q4 2024
$-0.46
Q1 2025
$-0.41
Q2 2025
$-0.61
Q3 2025
$-0.73
Q4 2025
$-0.31
Q1 2026
$-0.30
Q2 2026
Latest RevenueN/A
Latest Net Income-32782000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$0.300-32782000+26.8%
Q1 2026-$0.310-29613000+32.6%
Q4 2025-$0.730-62498000-62.2%
Q3 2025-$0.610-47712000-154.2%
Q2 2025-$0.410-26182000-20.6%
Q1 2025-$0.460-29281000-70.4%
Q4 2024-$0.450-28824000-50.0%
Q3 2024-$0.240-15499000-14.3%
Q2 2024-$0.340-21627000
Q1 2024-$0.270-14654000
Q4 2023-$0.300-12993000
Q3 2023-$0.210-9064000
Larimar Therapeutics (LRMR) — Earnings